Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016).
Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence.
Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
A Model for Studying Nasal Drug Delivery: RPMI 2650 Human Nasal Epithelial Cell Line
Department of Pharmaceutical Technology, University of Szeged, Szeged, Hungary
Laboratory of Molecular Neurobiology, Institute of Biophysics, Biological Research Center, Hungarian Academy of Sciences, Szeged, Hungary
Author to whom correspondence should be addressed.
Received: 12 July 2010 / Accepted: 12 July 2010 / Published: 12 July 2010
PDF [150 KB, uploaded 30 September 2016]
Note: In lieu of an abstract, this is an excerpt from the first page.
Studies on nasal epithelial models are important to develop vehicles for systemic nasal drug delivery, and also for targeting drugs to brain via the nasal route. [...]
This is an open access article distributed under the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
KÜRTI, L.; KIS, L.; VESZELKA, S.; SZABÓ-RÉVÉSZ, P.; DELI, M.A. A Model for Studying Nasal Drug Delivery: RPMI 2650 Human Nasal Epithelial Cell Line. Sci. Pharm. 2010, 78, 579.
KÜRTI L, KIS L, VESZELKA S, SZABÓ-RÉVÉSZ P, DELI MA. A Model for Studying Nasal Drug Delivery: RPMI 2650 Human Nasal Epithelial Cell Line. Scientia Pharmaceutica. 2010; 78(3):579.
KÜRTI, L.; KIS, L.; VESZELKA, S.; SZABÓ-RÉVÉSZ, P.; DELI, M. A. 2010. "A Model for Studying Nasal Drug Delivery: RPMI 2650 Human Nasal Epithelial Cell Line." Sci. Pharm. 78, no. 3: 579.
Show more citation formats
Show less citations formats
[Return to top]
For more information on the journal statistics, click here
Multiple requests from the same IP address are counted as one view.